HIGHLIGHTS
- who: Chimeric Anti-Staphylococcal Enterotoxin B and colleagues from the Department of Biology, Amherst College, Amherst, Massachusetts, United States of America, Department of Veterinary and Animal Sciences, University of have published the research: Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEB, in the Journal: (JOURNAL) of November/15,/2011
- how: Given the known immunomodulatory functions of statins and their established ability to inhibit T-cell as well as cytokine/chemokine signaling the authors evaluated lovastatin in this study.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.